Abstract
This exploratory analysis of a randomized clinical trial evaluates the effect of neprilysin inhibition on Alzheimer disease blood biomarkers in patients with heart disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have